<body><p>HR 923 IH</p><p/><center><p>113th CONGRESS</p></center>
<p/><center><p>1st Session</p></center>
<p/><center><p>H. R. 923</p></center>
<p>To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs.</p><p/><center><p>IN THE HOUSE OF REPRESENTATIVES</p></center>
<p/><h3><center><p>February 28, 2013</p></center></h3>
<p>Mr. NADLER introduced the following bill; which was referred to the Committee on Ways and Means</p><hr/><p/><center><p>A BILL</p></center>
<p>To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs.</p><ul><p><em>  Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</em></p></ul><p/><h3>SECTION 1. SHORT TITLE.</h3>
<ul><p>This Act may be cited as the &#8216;Say No to Drug Ads Act&#8217;.</p></ul><p/><h3>SEC. 2. DISALLOWANCE OF DEDUCTION FOR DIRECT-TO-CONSUMER ADVERTISEMENT OF PRESCRIPTION DRUGS.</h3>
<ul><p>(a) General Rule- Part IX of subchapter B of chapter 1 of the Internal Revenue Code of 1986 (relating to items not deductible) is amended by adding at the end the following new section:</p></ul><p/><blockquote><h3>&#8216;SEC. 280I. DIRECT-TO-CONSUMER ADVERTISEMENT OF PRESCRIPTION DRUGS.</h3>
<ul><p>&#8216;No deduction shall be allowed under this chapter for any amount paid or incurred for a direct-to-consumer advertisement of a prescription drug.&#8217;.</p><p>(b) Clerical Amendment- The table of sections for part IX of subchapter B of chapter 1 of such Code is amended by adding at the end thereof the following new item:</p><ul><p>&#8216;Sec. 280I. Direct-to-consumer advertisement of prescription drugs.&#8217;.</p></ul><p>(c) Effective Date- The amendments made by this section shall apply to amounts paid or incurred after December 31, 2013.</p></ul></blockquote></body>